Mikhail Burmakin | Karolinska Institutet

Stäng

Ett medicinskt universitet

Sök

Meny

Ett medicinskt universitet

Publikationer
Populärvetenskap och samverkan

Artiklar

Article: JOURNAL OF TRANSLATIONAL MEDICINE. 2017;15(1):47

Imatinib increases oxygen delivery in extracellular matrix-rich but not in matrix-poor experimental carcinoma.

Burmakin M; van Wieringen T; Olsson PO; Stuhr L; Åhgren A; Heldin C-H; Reed RK; Rubin K; Hellberg C
Article: CLINICAL CANCER RESEARCH. 2013;19(18):5092-5103

Dual targeting of wild-type and mutant p53 by small molecule RITA results in the inhibition of N-Myc and key survival oncogenes and kills neuroblastoma cells in vivo and in vitro.

Burmakin M; Shi Y; Hedström E; Kogner P; Selivanova G
Article: PLOS ONE. 2009;4(12):e8149

Combined anti-angiogenic therapy targeting PDGF and VEGF receptors lowers the interstitial fluid pressure in a murine experimental carcinoma.

Kłosowska-Wardega A; Hasumi Y; Burmakin M; Ahgren A; Stuhr L; Moen I; Reed RK; Rubin K; Hellberg C; Heldin C-H

Nyheter från KI

Kalenderhändelser från KI